China Touyun Tech Group (HK:1332) has released an update.
Touyun Biotech Group Limited reported a reduction in its half-year losses for the period ending June 30, 2024, with the loss decreasing from HK$85.1 million in 2023 to HK$48.8 million. The company saw a significant drop in revenue from sales of goods and services, but also managed to cut costs, leading to a lower loss per share year-over-year. Despite the losses, there was a slight other comprehensive income gain due to foreign exchange differences.
For further insights into HK:1332 stock, check out TipRanks’ Stock Analysis page.
